IP Library Granted Patent US 9,789,228
Granted Patent B2
US 9,789,228 · App. 14/567,183 · Granted Oct 17, 2017

Antimicrobial coatings for medical devices and processes for preparing such coatings

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,789,228
App. No.
14/567,183
Granted
Oct 17, 2017
Kind
B2
Abstract

Antimicrobial formulations and coatings for medical devices and processes therefor are disclosed. The formulations include at least one water permeable polymer with at least one antimicrobial agent in a liquid medium and are prepared by wet milling the components and can form antimicrobial coatings having uniformly dispersed particles having an average size of no greater than 50 microns.

Claims (17)

1. A process of forming an antimicrobial formulation for coating a medical device, the process comprising milling at least one water permeable polymer which is dissolved in a liquid medium with at least one antimicrobial agent which is insoluble in the liquid medium to form the antimicrobial formulation in which the at least one water permeable polymer encapsulates the at least one antimicrobial agent; and adding a primary C 1-6 alcohol to the antimicrobial formulation;

wherein the at least one antimicrobial agent includes a silver-based antimicrobial agent and wherein the at least one water permeable polymer includes at least one of a polyurethane or a thermoplastic polyurethane elastomer.

2. The process of claim 1 , wherein the at least one water permeable polymer has a weight average molecular weight of from about 70,000 to about 120,000 Daltons.

3. The process of claim 1 , wherein the at least one antimicrobial agent includes the silver-based antimicrobial agent and a second antimicrobial agent which is a polybiguanide or salt thereof.

4. The process of claim 1 , wherein the at least one antimicrobial agent includes silver sulfadiazine, as the silver-based antimicrobial agent, and a second antimicrobial agent which is chlorhexidine diacetate.

5. The process of claim 1 , wherein the liquid medium includes one or more of an alcohol; an ether; a ketone; an organic acid; an organic ester; an amide; a hydrocarbon; or a halogenated solvent or liquid.

6. The process of claim 1 , wherein the liquid medium includes an ether and a primary C 1-6 alcohol.

7. The process of claim 1 , wherein the at least one antimicrobial agent is insoluble in the formulation and the formulation is milled until the insoluble antimicrobial agent has a mean particle size of no greater than 50 microns.

8. The process of claim 1 , comprising initially preparing a polymer solution having a viscosity of from about 100 centipoise (cP) to about 1000 cP by dissolving the at least one water permeable polymer in the liquid medium and then adding the antimicrobial agent to the solution followed by milling the formulation.

9. The process of claim 8 , further comprising adding a second antimicrobial agent to the formulation after milling, and further milling the formulation with the second antimicrobial agent.

10. The process of claim 9 , wherein the primary C 1-6 alcohol is methanol, ethanol, n-propanol, n-butanol, n-pentanol, and/or n-hexanol.

11. A process of forming an antimicrobial coating on a medical device, the process comprising:

applying the antimicrobial formulation of claim 1 on a medical device to form an antimicrobial coating on the medical device.

12. The process of claim 11 , wherein the medical device is selected from the group consisting of a dialysis catheter, a urological catheter, an enteral feeding tube, a surgical staple, a trocar, an implant, suture, a respiratory tube, a surgical plate, a surgical screw, a wire, and a hernia mesh.

13. The process of claim 11 , wherein the coating has a thickness of between about 20 microns to about 80 microns.

14. The process of claim 11 , wherein applying the formulation on the medical device comprises dip-coating the medical device in the formulation and then drying the antimicrobial formulation by driving off the liquid medium to form the antimicrobial coating on the medical device.

15. The process of claim 11 , wherein the at least one antimicrobial agent includes a combination of silver sulfadiazine and chlorhexidine diacetate.

Assignments (3)
SECURITY INTEREST Recorded Dec 1, 2025
From: MOZARC MEDICAL US LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP
Reel/Frame 073800/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2023
From: COVIDIEN LP
To: MOZARC MEDICAL US LLC
Reel/Frame 063375/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2014
From: TRAMONTANO, VALENTINO; MARSDEN, BRENT; ALMEIDA, ROBERT; DAHL, ERIC; RAWLINS, JAMES; MENDON, SHARATHKUMAR
To: COVIDIEN LP
Reel/Frame 034479/0868 →